Zusammenfassung
Disorders of ketone body metabolism present either in the first few days of life or later in childhood, during an infection or some other metabolic stress. There are two defects of ketogenesis, 3-hydroxy-3-methylglutaryl (HMG)-CoA lyase deficiency and HMG-CoA synthase deficiency. In these, decompensation leads to encephalopathy, with vomiting and a reduced level of consciousness, often accompanied by hepatomegaly. The biochemical features – hypoketotic hypoglycaemia, with or without hyperammonaemia – resemble those seen in fatty acid oxidation disorders. The organic acids are diagnostic in HMG-CoA lyase deficiency. In HMG-CoA synthase deficiency, the organic acids are characteristic during decompensation but normal at other times. Ketone body utilisation is catalysed bysuccinyl-CoA:3-ketoacid CoA transferase (SCOT)and mitochondrial acetoacetyl-CoA thiolase (T2). Deficiencies of SCOT, T2 or the monocarboxylate transporter 1 (MCT1) present with episodes of ketoacidosis. This is often accompanied by dehydration and decreased consciousness. The organic acids usually show characteristic abnormalities in T2 deficiency but there are no specific findings in SCOT or MCT1 deficiencies and diagnosis relies on molecular analysis. In all these disorders, the primary aim of treatment is to prevent decompensation. Fasting is avoided and a high glucose intake is maintained at times of metabolic stress, such as infections. This chapter also briefly discusses the use of ketogenic diets in inherited metabolic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fukao T, Mitchell G, Sass JO et al. (2014) Ketone body metabolism and its defects. J Inherit Metab Dis 37:541–551
Pitt JJ, Peters H, Boneh A et al. (2015) Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency: urinary organic acid profiles and expanded spectrum of mutations. J Inherit Metab Dis 38:459–466
Reimao S, Morgado C, Almeida IT et al. (2009) 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: initial presentation in a young adult. J Inherit Metab Dis 32:S49–52
Gibson KM, Cassidy SB, Seaver LH et al. (1994) Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. J Inherit Metab Dis 17:291–294
van der Knaap MS, Bakker HD, Valk J (1998) MR imaging and proton spectroscopy in 3-hydroxy-3-methylglutaryl coenzyme A lyase deficiency. AJNR Am J Neuroradiol 19:378–382
Pie J, Lopez-Vinas E, Puisac B et al. (2007) Molecular genetics of HMG-CoA lyase deficiency. Mol Genet Metab 92:198–209
Thompson GN, Chalmers RA, Halliday D (1990) The contribution of protein catabolism to metabolic decompensation in 3-hydroxy-3-methylglutaric aciduria. Eur J Pediatr 149:346–350
Langendonk JG, Roos JC, Angus L et al. (2012) A series of pregnancies in women with inherited metabolic disease. J Inherit Metab Dis 35:419–424
Fukao T, Scriver CR, Kondo N (2001) The clinical phenotype and outcome of mitochondrial acetoacetyl-CoA thiolase deficiency (beta-ketothiolase or T2 deficiency) in 26 enzymatically proved and mutation-defined patients. Mol Genet Metab 72:109–114
van Hasselt PM, Ferdinandusse S, Monroe GR et al. (2014) Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med 371:1900–1907
Ozand PT, Rashed M, Gascon GG et al. (1994) 3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms. Brain Dev 16:S38–45
Paquay S, De Lonlay P, Dobbelaere D et al. (2015) Basal ganglia involvement in mitochondrial acetoacetyl-CoA thiolase deficiency. J Inherit Metab Dis 38:S187
Balasubramaniam S, Lewis B, Greed L et al. (2016) Heterozygous monocarboxylate transporter 1 (MCT1, SLC16A1) deficiency as a cause of recurrent ketoacidosis. JIMD Rep (in press)
Otonkoski T, Jiao H, Kaminen-Ahola N et al. (2007) Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 81:467–474
Merezhinskaya N, Fishbein WN, Davis JI et al. (2000) Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve 23:90–97
Sasai H, Aoyama Y, Ohtsuka H et al. (2015) OXCT1 heterozygous carriers could develop severe ketoacidotic episodes in conjunction with ketogenic stress. J Inherit Metab Dis 38:S194
Fukao T, Maruyama S, Ohura T et al. (2012) Three Japanese patients with beta-ketothiolase deficiency who share a mutation, c.431A>C (H144P) in ACAT1: subtle abnormality in urinary organic acid analysis and blood acylcarnitine analysis using tandem mass spectrometry. JIMD Rep 3:107–115
Bennett MJ, Hosking GP, Smith MF et al. (1984) Biochemical investigations on a patient with a defect in cytosolic acetoacetyl-CoA thiolase, associated with mental retardation. J Inherit Metab Dis 7:125–128
Lutas A, Yellen G (2013) The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci 36:32–40
Kossoff EH, Zupec-Kania BA, Amark PE et al. (2009) Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 50:304–317
Klepper J, Leiendecker B (2013) Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol 28:1045–1048
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Morris, A.A.M. (2016). Disorders of Ketogenesis and Ketolysis. In: Saudubray, JM., Baumgartner, M., Walter, J. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49771-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-49771-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-49769-2
Online ISBN: 978-3-662-49771-5
eBook Packages: MedicineMedicine (R0)